Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Dec 31, 2018
Sep 30, 2018
Jun 30, 2018
Mar 31, 2018
Total Revenue
193,718
155,054
170,911
174,386
Cost of Revenue
123,908
95,913
104,383
99,036
Gross Profit
69,810
59,141
66,528
75,350
Operating Expenses
Research Development
9,723
9,810
8,335
2,730
Selling General and Administrative
23,197
20,588
20,553
14,112
Non Recurring
--
--
--
--
Others
0
0
0
8,293
Total Operating Expenses
32,920
30,398
28,888
25,135
Operating Income or Loss
36,890
28,743
37,640
50,215
Income from Continuing Operations
Total Other Income/Expenses Net
(369)
(370,438)
(28,688)
(16,878)
Earnings Before Interest And Taxes
36,521
(341,695)
8,952
33,337
Interest Expense
21,512
21,433
21,194
22,842
Income Before Tax
15,009
(363,128)
(12,242)
10,495
Income Tax Expense
2,647
(75,600)
(883)
(2,275)
Minority Interest
--
--
0
--
Net Income From Continuing Ops
12,362
(287,528)
(11,359)
12,770
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
12,362
(287,528)
(11,359)
12,770
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
12,362
(287,528)
(11,359)
12,770